[Federal Register Volume 72, Number 156 (Tuesday, August 14, 2007)]
[Notices]
[Pages 45429-45430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-15896]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-07-07BF]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Formative Research on Lung Cancer Screening--New--Division of 
Cancer Prevention and Control, National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    Currently, there is scientific debate about the value of lung 
cancer screening. For people in whom lung cancer is found and treated 
at an early, localized stage, the five-year survival rate is roughly 
49%. However, only 16% of people with lung cancer are diagnosed at this 
early, localized stage. Screening for lung cancer using chest x-rays 
(CXR) was widely practiced, but studies have shown that CXR with or 
without sputum cytology does not reduce mortality from lung cancer. 
Studies are currently underway to provide more information about the 
effectiveness of other types of screening tests, such as computed 
tomography (CT) scans and spiral CT scans.
    The purpose of this project is to conduct formative research to 
gather information from adult consumers and primary care physicians 
about experiences and practices related to lung cancer screening and 
testing as well as their knowledge, attitudes, and behaviors related to 
preventive cancer

[[Page 45430]]

screenings overall. Of particular interest are adults aged 40-70 years 
of various races and ethnicities who are at high risk for lung cancer 
(i.e., long-term heavy smokers).
    The proposed project will use focus groups to gather information 
about the target audiences' experiences and practices related to lung 
cancer screening and testing. If warranted from focus group data with 
adult consumers, follow-up personal interviews will be conducted with 
selected focus group participants, especially those reporting 
experience with screening tests, such as spiral computed tomography 
(CT).
    A total of 16 focus groups will be conducted at professional focus 
group facilities with long term heavy smokers aged 40-70. The data will 
be collected from a convenience sample of adults who will be screened 
and recruited using lists maintained by the focus group facilities. 
Each focus group will include approximately nine participants and last 
two hours. If warranted, one-hour telephone follow-up interviews will 
be conducted with up to 16 participants within one month of the focus 
groups.
    Four telephone focus groups will be conducted with primary care 
physicians. The American Medical Association Physician Masterfile list 
will be used to recruit a random sample of physicians for participation 
in the focus groups. Potential participants (physicians) will be mailed 
a screening packet to complete and return. Each of the four focus 
groups will include approximately eight participants and last 75 
minutes.
    There are no costs to respondents except their time to participate 
in the survey.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden/
                   Respondents                       Number of      responses/     response  (in   Total burden
                                                    respondents     respondent        hours)        (in hours)
----------------------------------------------------------------------------------------------------------------
Patient Participants Screener...................             288               1            2/60              10
Patient Focus Group Participants................             144               1               2             288
Patient Follow-up Interview In Depth                          16               1               1              16
 Participants...................................
Physician Participants Screener.................              96               1            5/60               8
Physician Focus Group Participants..............              32               1            1.15              40
                                                 ---------------------------------------------------------------
    Total.......................................             362  ..............  ..............             362
----------------------------------------------------------------------------------------------------------------


    Dated: August 8, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E7-15896 Filed 8-13-07; 8:45 am]
BILLING CODE 4163-18-P